Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

A. Yoshimi, P. Bader, S. Matthes-Martin, J. Starý, P. Sedlacek, U. Duffner, T. Klingebiel, D. Dilloo, W. Holter, F. Zintl, B. Kremens, K. W. Sykora, C. Urban, H. Hasle, E. Korthof, T. Révész, A. Fischer, P. Nöllke, F. Locatelli, C. M. Niemeyer

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative disorder of early childhood. In all, 21 patients with JMML who received donor leukocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) for either mixed chimerism (MC, n=7) or relapse (n=14) were studied. Six patients had been transplanted from an HLA-matched sibling and 15 from other donors. Six of the 21 patients (MC: 3/7 patients; relapse: 3/14 patients) responded to DLI. Response rate was significantly higher in patients receiving a higher total T-cell dose (≥ × 107/kg) and in patients with an abnormal karyotype. None of the six patients receiving DLI from a matched sibling responded. Response was observed in five of six patients who did and in one of 15 children who did not develop acute graft-versus-host disease following DLI (P = 0.01). The overall outcome was poor even for the responders. Only one of the responders is alive in remission, two relapsed, and three died of complications. In conclusion, this study shows that some cases of JMML may be sensitive to DLI, this providing evidence for a graft-versus-leukemia effect in JMML. Infusion of a high number of T cells, strategies to reduce toxicity, and cytoreduction prior to DLI may improve the results.

Original languageEnglish
Pages (from-to)971-977
Number of pages7
JournalLeukemia
Volume19
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Juvenile Myelomonocytic Leukemia
Hematopoietic Stem Cell Transplantation
Leukocytes
Tissue Donors
Siblings
Abnormal Karyotype
T-Lymphocytes
Recurrence
Myeloproliferative Disorders
Chimerism
Graft vs Host Disease
Leukemia

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Donor leukocyte infusion
  • Graft-versus-host disease
  • Graft-versus-leukemia effect
  • Juvenile myelomonocytic leukemia
  • Mixed chimerism

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Yoshimi, A., Bader, P., Matthes-Martin, S., Starý, J., Sedlacek, P., Duffner, U., ... Niemeyer, C. M. (2005). Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia, 19(6), 971-977. https://doi.org/10.1038/sj.leu.2403721

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. / Yoshimi, A.; Bader, P.; Matthes-Martin, S.; Starý, J.; Sedlacek, P.; Duffner, U.; Klingebiel, T.; Dilloo, D.; Holter, W.; Zintl, F.; Kremens, B.; Sykora, K. W.; Urban, C.; Hasle, H.; Korthof, E.; Révész, T.; Fischer, A.; Nöllke, P.; Locatelli, F.; Niemeyer, C. M.

In: Leukemia, Vol. 19, No. 6, 06.2005, p. 971-977.

Research output: Contribution to journalArticle

Yoshimi, A, Bader, P, Matthes-Martin, S, Starý, J, Sedlacek, P, Duffner, U, Klingebiel, T, Dilloo, D, Holter, W, Zintl, F, Kremens, B, Sykora, KW, Urban, C, Hasle, H, Korthof, E, Révész, T, Fischer, A, Nöllke, P, Locatelli, F & Niemeyer, CM 2005, 'Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia', Leukemia, vol. 19, no. 6, pp. 971-977. https://doi.org/10.1038/sj.leu.2403721
Yoshimi, A. ; Bader, P. ; Matthes-Martin, S. ; Starý, J. ; Sedlacek, P. ; Duffner, U. ; Klingebiel, T. ; Dilloo, D. ; Holter, W. ; Zintl, F. ; Kremens, B. ; Sykora, K. W. ; Urban, C. ; Hasle, H. ; Korthof, E. ; Révész, T. ; Fischer, A. ; Nöllke, P. ; Locatelli, F. ; Niemeyer, C. M. / Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. In: Leukemia. 2005 ; Vol. 19, No. 6. pp. 971-977.
@article{3b02074a2d20433185a7c7c2f3fc961b,
title = "Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia",
abstract = "Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative disorder of early childhood. In all, 21 patients with JMML who received donor leukocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) for either mixed chimerism (MC, n=7) or relapse (n=14) were studied. Six patients had been transplanted from an HLA-matched sibling and 15 from other donors. Six of the 21 patients (MC: 3/7 patients; relapse: 3/14 patients) responded to DLI. Response rate was significantly higher in patients receiving a higher total T-cell dose (≥ × 107/kg) and in patients with an abnormal karyotype. None of the six patients receiving DLI from a matched sibling responded. Response was observed in five of six patients who did and in one of 15 children who did not develop acute graft-versus-host disease following DLI (P = 0.01). The overall outcome was poor even for the responders. Only one of the responders is alive in remission, two relapsed, and three died of complications. In conclusion, this study shows that some cases of JMML may be sensitive to DLI, this providing evidence for a graft-versus-leukemia effect in JMML. Infusion of a high number of T cells, strategies to reduce toxicity, and cytoreduction prior to DLI may improve the results.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Donor leukocyte infusion, Graft-versus-host disease, Graft-versus-leukemia effect, Juvenile myelomonocytic leukemia, Mixed chimerism",
author = "A. Yoshimi and P. Bader and S. Matthes-Martin and J. Star{\'y} and P. Sedlacek and U. Duffner and T. Klingebiel and D. Dilloo and W. Holter and F. Zintl and B. Kremens and Sykora, {K. W.} and C. Urban and H. Hasle and E. Korthof and T. R{\'e}v{\'e}sz and A. Fischer and P. N{\"o}llke and F. Locatelli and Niemeyer, {C. M.}",
year = "2005",
month = "6",
doi = "10.1038/sj.leu.2403721",
language = "English",
volume = "19",
pages = "971--977",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

AU - Yoshimi, A.

AU - Bader, P.

AU - Matthes-Martin, S.

AU - Starý, J.

AU - Sedlacek, P.

AU - Duffner, U.

AU - Klingebiel, T.

AU - Dilloo, D.

AU - Holter, W.

AU - Zintl, F.

AU - Kremens, B.

AU - Sykora, K. W.

AU - Urban, C.

AU - Hasle, H.

AU - Korthof, E.

AU - Révész, T.

AU - Fischer, A.

AU - Nöllke, P.

AU - Locatelli, F.

AU - Niemeyer, C. M.

PY - 2005/6

Y1 - 2005/6

N2 - Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative disorder of early childhood. In all, 21 patients with JMML who received donor leukocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) for either mixed chimerism (MC, n=7) or relapse (n=14) were studied. Six patients had been transplanted from an HLA-matched sibling and 15 from other donors. Six of the 21 patients (MC: 3/7 patients; relapse: 3/14 patients) responded to DLI. Response rate was significantly higher in patients receiving a higher total T-cell dose (≥ × 107/kg) and in patients with an abnormal karyotype. None of the six patients receiving DLI from a matched sibling responded. Response was observed in five of six patients who did and in one of 15 children who did not develop acute graft-versus-host disease following DLI (P = 0.01). The overall outcome was poor even for the responders. Only one of the responders is alive in remission, two relapsed, and three died of complications. In conclusion, this study shows that some cases of JMML may be sensitive to DLI, this providing evidence for a graft-versus-leukemia effect in JMML. Infusion of a high number of T cells, strategies to reduce toxicity, and cytoreduction prior to DLI may improve the results.

AB - Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative disorder of early childhood. In all, 21 patients with JMML who received donor leukocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) for either mixed chimerism (MC, n=7) or relapse (n=14) were studied. Six patients had been transplanted from an HLA-matched sibling and 15 from other donors. Six of the 21 patients (MC: 3/7 patients; relapse: 3/14 patients) responded to DLI. Response rate was significantly higher in patients receiving a higher total T-cell dose (≥ × 107/kg) and in patients with an abnormal karyotype. None of the six patients receiving DLI from a matched sibling responded. Response was observed in five of six patients who did and in one of 15 children who did not develop acute graft-versus-host disease following DLI (P = 0.01). The overall outcome was poor even for the responders. Only one of the responders is alive in remission, two relapsed, and three died of complications. In conclusion, this study shows that some cases of JMML may be sensitive to DLI, this providing evidence for a graft-versus-leukemia effect in JMML. Infusion of a high number of T cells, strategies to reduce toxicity, and cytoreduction prior to DLI may improve the results.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Donor leukocyte infusion

KW - Graft-versus-host disease

KW - Graft-versus-leukemia effect

KW - Juvenile myelomonocytic leukemia

KW - Mixed chimerism

UR - http://www.scopus.com/inward/record.url?scp=20044393759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044393759&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403721

DO - 10.1038/sj.leu.2403721

M3 - Article

VL - 19

SP - 971

EP - 977

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 6

ER -